Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Invitrx Therapeutics Inc.
FDA Inspection
•Invitrx Therapeutics Inc.•April 30, 2025

Invitrx Therapeutics Inc. – FDA Inspection, Apr 30, 2025

Record Details

This FDA Inspection record concerns Invitrx Therapeutics Inc., with an inspection on April 30, 2025, issued by the Los Angeles District Office, covering biologics.

Company
Invitrx Therapeutics Inc.
Inspection Date
April 30, 2025
Product Type
Biologics
Office
Los Angeles District Office
People
  • Creighton T. Tuzon (Issuing Officer)
  • Laurissa S. Flowers (Issuing Officer)
View Company Profile

ID · 08b1cfe9-b127-4584-818e-f5554d7b3a3d

Inspection Facts

Inspection number
1265382
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued, view the record

FDA Citations

9
  1. 21 CFR 1271.160(a)All core requirements covered in program
  2. 21 CFR 1271.180(a)Procedures to meet core CTGP
  3. 21 CFR 1271.200(a)Cleaned, sanitized per established schedules
  4. 21 CFR 1271.260(a)Contamination, mix ups, improper release
  5. 21 CFR 1271.265(c)(1)Release of HCT/Ps by responsible person
  6. 21 CFR 1271.270(b)Organized to facilitate review
  7. 21 CFR 1271.290(e)Documenting disposition of each HCT/P
  8. 21 CFR 1271.50(a)Determination based on screening and testing
  9. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Invitrx Therapeutics Inc.

3
DateClassificationOfficeProject area
March 22, 2022OAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 13, 2019VAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
April 3, 2019OAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Invitrx Therapeutics Inc.
  • FDA Inspection 1165854 - 2022-03-22
  • FDA Inspection 1101970 - 2019-09-13
  • FDA Inspection 1084910 - 2019-04-03

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Invitrx Therapeutics Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.